NewsRoom Articles - Page 22 of 224

TuesdayMay 20, 2025 9:45 am

Intelligent Bio Solutions Inc. (NASDAQ: INBS) Targets Global Sales Growth with Multilingual Digital Rollout

Medical technology company Intelligent Bio Solutions has launched Arabic, Italian, and Spanish websites to support expansion into key international markets. The move opens digital access to over 1.4 billion people across Latin America, the Middle East, and Southern Europe. The rollout aligns with increased demand for non-invasive workplace drug testing and compliance tools. INBS’s flagship fingerprint sweat-based drug screening system is currently used by over 450 clients in 24 countries. The company plans a U.S. market launch in 2025 as it continues to develop additional biosensor applications. Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company specializing in rapid, non-invasive…

TuesdayMay 20, 2025 9:00 am

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Is ‘One to Watch’

NRx Pharmaceuticals is advancing a pipeline of innovative therapies targeting multibillion-dollar unmet needs in central nervous system disorders. The company’s lead candidate, NRX-100 (preservative free IV ketamine), NDA in process with the FDA, has been granted Fast Track designation by the FDA for acute suicidal depression, and a patent for this novel formulation has been filed with the U.S. Patent and Trademark Office. NRX-101 (oral D-cycloserine/lurasidone), has received FDA Breakthrough Therapy designation, expediting its development. HOPE Therapeutics, NRx’s interventional psychiatry subsidiary, is targeting $100M in forward looking revenue by year-end 2025, through development of a national clinic network treating suicidal depression,…

MondayMay 19, 2025 2:30 pm

Republican Lawmakers Embrace Psychedelic Therapies in Shift Toward Veteran Mental Health Reform

Rep. Morgan Luttrell (R-Texas), a retired Navy SEAL, is part of a rising wave of Republican lawmakers advocating for the therapeutic use of psychedelics to treat PTSD, depression, and suicidality among veterans—a movement recently spotlighted by The Wall Street Journal. After undergoing ibogaine and DMT therapy in Mexico in 2018, Luttrell described the experience as transformative, helping him confront trauma and save his marriage. Now in Congress, he’s pushing for science-based, medically supervised access to Schedule I drugs like ibogaine, psilocybin, and MDMA. Joined by fellow veterans in office, including Rep. Dan Crenshaw (R-Texas) and Rep. Jack Bergman (R-Mich.), Luttrell…

MondayMay 19, 2025 9:45 am

Soligenix Inc. (NASDAQ: SNGX) Reports Q1 Milestones, Financial Results

Q1 milestones are representative of Soligenix’s commitment to advance its pipeline of therapeutic candidates, focusing on areas with significant unmet medical needs. The company noted positive interim results from the ongoing open-label, investigator-initiated study (“IIS”) evaluating extended HyBryte(TM) treatment. Soligenix announced the release of a publication describing the preclinical efficacy of CiVax(TM), a thermostabilized subunit vaccine against SARS-CoV-2. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company dedicated to developing and commercializing treatments for rare diseases, recently announced its financial results for the first quarter of 2025, alongside a summary of the company’s latest accomplishments (https://ibn.fm/OMQmM). These milestones are representative of Soligenix’s continued…

MondayMay 19, 2025 9:00 am

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Names Experienced Life Science Leader as New CEO

Experienced leadership contributes to key performance indicators. Dr. Eric Poma brings more than 30 years of experience to his new role as CLDI CEO. His expertise will help the company develop and advance proprietary groundbreaking therapies. Effective leadership is a cornerstone of organizational success, particularly in the dynamic and high-stakes realm of biotechnology. Recognizing the pivotal role of seasoned leadership, Calidi Biotherapeutics (NYSE American: CLDI) has announced the appointment of Eric Poma, PhD, as its new Chief Executive Officer and member of the board of directors (https://ibn.fm/qMEu4). This strategic transition underscores Calidi’s commitment to advancing its innovative cancer therapies under experienced guidance. Dr.…

FridayMay 16, 2025 10:00 am

New Multimodal AI System Boosts the Accuracy of Lung Cancer Screening

Early diagnosis of lung cancer is pivotal to effective treatment because this disease is very challenging to treat. Advances in AI are transforming the screening for this disease, improving both efficiency and accuracy. Existing screening methods such as low-dose CT have several challenges. These include high rates of false-positives and a high variability when reporting other incidental but critical information, such as findings on cardiovascular diseases. Furthermore, the shortage of radiologists around the world means that less than 10% of people who need low-dose CT scans can actually undergo them. New research published in the journal Nature Communications shows that…

ThursdayMay 15, 2025 10:00 am

Will Trump’s Executive Order on Drug Prices Yield the Desired Results

While President Trump signed an order aimed at reducing the high cost of prescription drugs in the U.S., it isn’t clear how exactly the price reduction will be achieved and how such reductions could impact the country in the long term. The President said patients in America pay a lot more for prescription drugs than the cost incurred for the same drugs in other countries. He added that he was going to order drug firms to slash their prices within the U.S. There has been a growing concern about the high cost of prescription drugs in America and data exists…

TuesdayMay 13, 2025 10:00 am

Study Links Higher Consumption of Ultra-Processed Foods to Heightened Psoriasis Risk

A recently conducted study has found a strong link between the intake of ultra-processed foods (UPFs) and a higher risk of developing psoriasis. The findings of this research appeared in the Nutrients journal. People suffering from psoriasis have lesions/patches that are itchy, scaly and inflamed. They commonly affect the nails, soles and palms, although the condition can manifest on any part of the body. The condition can also elevate the risk of a number of mental health problems, such as anxiety and depression, in addition to increasing the risk for Crohn’s disease and cardiovascular disease. While there currently isn’t a…

TuesdayMay 13, 2025 9:45 am

Nutriband Inc. (NASDAQ: NTRB) Pioneers Innovative Approach to Opioid Crisis with Game-Changing Transdermal Patch

The opioid epidemic has prompted a re-evaluation of pain-management strategies, highlighting the importance of balancing effective treatment with abuse prevention Nutriband’s AVERSA(TM) Fentanyl represents a significant advancement in this domain The company’s strategic development of AVERSA Fentanyl follows a structured pharmaceutical lifecycle As the opioid crisis continues to challenge public health systems, the need for innovative solutions has become increasingly apparent. Rather than relying solely on restrictive measures, companies such as Nutriband (NASDAQ: NTRB) are exploring technological advancements to mitigate abuse while ensuring patient access to necessary medications. Nutriband’s development of AVERSA(TM) Fentanyl, an abuse-deterrent transdermal patch, exemplifies this forward-thinking approach (https://ibn.fm/jhHMY). The…

FridayMay 09, 2025 10:00 am

Study Reveals Early Development of Pediatric Brain Tumors in Specialized Nerve Cells

Medulloblastoma is a commonly occurring pediatric brain cancer in kids and adolescents. The cancer develops within the cerebellum, the part of the brain responsible for coordinating movement and other functions. These tumors enlarge quickly, can grow into nearby tissues, and in some cases, can metastasize. The variations in these tumors make it challenging to find appropriate treatments. Now a recent study in Germany has come up with findings which shed light on the exact location where these aggressive tumors normally first develop. The findings appeared in the Nature journal. The study’s first author Konstantin Okonechnikov explains that they genetically characterized…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Intelligent Bio Solutions Inc. (NASDAQ: INBS) Targets Global Sales Growth with Multilingual Digital Rollout

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Is ‘One to Watch’

Republican Lawmakers Embrace Psychedelic Therapies in Shift Toward Veteran Mental Health Reform

Soligenix Inc. (NASDAQ: SNGX) Reports Q1 Milestones, Financial Results

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Names Experienced Life Science Leader as New CEO

New Multimodal AI System Boosts the Accuracy of Lung Cancer Screening

Will Trump’s Executive Order on Drug Prices Yield the Desired Results

Study Links Higher Consumption of Ultra-Processed Foods to Heightened Psoriasis Risk

Nutriband Inc. (NASDAQ: NTRB) Pioneers Innovative Approach to Opioid Crisis with Game-Changing Transdermal Patch

Study Reveals Early Development of Pediatric Brain Tumors in Specialized Nerve Cells

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search